LIANBIO
LianBio’s mission is to catalyze the development and accelerate availability of paradigm-shifting medicines to patients in China and major Asian markets through partnerships that provide access to the best science-driven therapeutic discoveries. LianBio collaborates with world-class partners across a diverse array of therapeutic and geographic areas to build out a pipeline based on disease relevance and the ability to impact patients with transformative mechanisms and precision-based therapeutics.
LIANBIO
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2019-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.lianbio.com
Total Employee:
101+
Status:
Active
Total Funding:
310 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Apache Microsoft Exchange Online Office 365 Mail IPv6
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
CymaBay Therapeutics
CymaBay Therapeutics is focused on the development and commercialization of proprietary new medicines for critical human diseases.
Cyteir Therapeutics
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
Navitor Pharmaceuticals
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
ValenzaBio
ValenzaBio is developing safe and effective treatment options for patients with autoimmune and inflammatory diseases.
Zai Lab
Zai Lab brings transformative medicines for cancer, autoimmune, and infectious diseases to patients in China and around the world.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
BlackRock
BlackRock investment in Series A - LianBio
Vida Ventures
Vida Ventures investment in Series A - LianBio
Perceptive Advisors
Perceptive Advisors investment in Series A - LianBio
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series A - LianBio
T. Rowe Price
T. Rowe Price investment in Series A - LianBio
Pfizer
Pfizer investment in Series A - LianBio
Viking Global Investors
Viking Global Investors investment in Series A - LianBio
Wellington Management
Wellington Management investment in Series A - LianBio
RA Capital Management
RA Capital Management investment in Series A - LianBio
Tybourne Capital Management
Tybourne Capital Management investment in Series A - LianBio
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-04 | LianBio Appoints Michael Humphries as Chief Scientific Advisor |
| 2021-03-18 | LianBio Announces Appointment of Yi Larson as Chief Financial Officer |
Official Site Inspections
http://www.lianbio.com Semrush global rank: 4.54 M Semrush visits lastest month: 2.32 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "LianBio"
LianBio - Crunchbase Company Profile & Funding
LianBio’s mission is to catalyze the development and accelerate availability of paradigm-shifting medicines to patients in China and major Asian markets through partnerships that provide …See details»
LianBio - LinkedIn
LianBio | 3,902 followers on LinkedIn. Biotechnology company dedicated to bringing paradigm-shifting medicines to patients in China and other Asian markets | LianBio’s mission is to …See details»
LianBio - AnnualReports.com
LianBio’s mission is to catalyze the development and accelerate availability of paradigm-shifting medicines to patients in China and other major Asian markets through partnerships that …See details»
LianBio - Overview, News & Similar companies | ZoomInfo.com
Dec 20, 2023 LianBio Enters into Agreement Assigning its Rights for NBTXR3 in China and Other Asian Markets SHANGHAI, China and PRINCETON, N.J., Dec. 26, 2023 (GLOBE …See details»
LianBio - The Org
LianBio’s mission is to catalyze the development and accelerate availability of paradigm-shifting medicines to patients in China and major Asian markets through partnerships that provide …See details»
LianBio Announces Departure of Chief Executive Officer
Dec 19, 2023 LianBio is a cross-border biotechnology company on a mission to bring transformative medicines to patients in China and other Asian markets. Through partnerships …See details»
LIANY - LianBio | Company Profile | OTC Markets
6 days ago LianBio. 103 Carnegie Center Drive. Suite 309. Princeton, NJ 08540 . www.lianbio.com +1 7325131804. [email protected]. Business Description. LianBio …See details»
LianBio (LIAN): history, ownership, mission, how it works & makes …
[relinking] Home History Owners Mission How It Works How It Makes Money A Brief History of LianBio (LIAN) Foundation and Early Years LianBio was founded in 2019, aiming to advance …See details»
LianBio - Products, Competitors, Financials, Employees, …
LianBio was founded in 2020. Where is LianBio's headquarters? LianBio's headquarters is located at 9th Floor, Kerry Parkside, 1155 Fangdian Road Unit 901-902, Shanghai. What is LianBio's …See details»
LianBio - Biotechnology Company
LianBio is a biotechnology company focused on bringing paradigm-shifting medicines to patients through partnerships that provide access to the best science-driven therapeutic discoveries.See details»
LianBio - Funding, Financials, Valuation & Investors - Crunchbase
LianBio is registered under the ticker NASDAQ:LIAN . Their stock opened with $16.00 in its Nov 1, 2021 IPO. ... How much funding has this organization raised over time? Show . Announced …See details»
LianBio - LinkedIn
LianBio | 3,930 followers on LinkedIn. Biotechnology company dedicated to bringing paradigm-shifting medicines to patients in China and other Asian markets | LianBio’s mission is to …See details»
LianBio - Contacts, Employees, Board Members, Advisors & Alumni
Organization. LianBio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... About. LianBio has 4 current employee profiles, …See details»
LianBio - Drug pipelines, Patents, Clinical trials - Synapse - Patsnap
LianBio operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs. The company is actively …See details»
LianBio Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 LianBio is a biopharmaceutical company that designs and provides innovative drugs and treatments for oncology and cardiology diseases. The company develops nine …See details»
LianBio Company Profile 2024: Stock Performance & Earnings
LianBio is a science-driven biopharmaceutical company dedicated to developing and commercializing medicines for patients with unmet medical needs, with an initial focus on in …See details»
LianBio Management Presentation
LianBio Management PresentationSee details»
LianBio Announces Formation of Scientific Advisory Board
Apr 14, 2022 Mathias Hukkelhoven, Ph.D., is an experienced global regulatory leader, and has served as a Strategic Advisor to LianBio since September 2021. Dr. Hukkelhoven previously …See details»
LianBio Company Overview, Contact Details & Competitors | LeadIQ
Oct 29, 2020 LianBio Confirms Receipt of Unsolicited Proposal from Concentra Biosciences. SHANGHAI, China and PRINCETON, N.J., Dec. 01, 2023 (GLOBE NEWSWIRE) -- The Board …See details»
How Does LianBio Work? – CBM - canvasbusinessmodel.com
Dec 19, 2024 [cbm_blg_rlnkng]LianBio is a groundbreaking biopharmaceutical company that is revolutionizing the way healthcare solutions are delivered to patients around the world. …See details»